ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
117.75
+1.27 (1.09%)
Apr 8, 2026, 10:31 AM EDT - Market open
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of $9.12 billion as of April 8, 2026. Its market cap has increased by 1,961.21% in one year.
Market Cap
9.12B
Enterprise Value
8.55B
1-Year Change
1,961.21%
Ranking
Category
Stock Price
$117.75
Market Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from $225.47M to $9.12B, an increase of 3,945.59%. That is a compound annual growth rate of 40.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 9.12B | -17.09% |
| Dec 31, 2025 | 11.00B | 2,382.10% |
| Dec 31, 2024 | 443.27M | -34.81% |
| Dec 29, 2023 | 679.99M | 513.79% |
| Dec 30, 2022 | 110.78M | -79.15% |
| Dec 31, 2021 | 531.29M | -8.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Exelixis | 11.40B |
| BioMarin Pharmaceutical | 10.67B |
| Praxis Precision Medicines | 8.64B |
| Axsome Therapeutics | 8.62B |
| Arrowhead Pharmaceuticals | 8.55B |
| Vaxcyte | 8.40B |
| Bio-Techne | 8.31B |
| Nuvalent | 8.29B |